Hyperglycemia in patients treated with the pan-PI3K inhibitor buparlisib (BKM120): characterization, management, and assessment for pharmacodynamics

被引：0
|
作者：
Azaro, A. [1 ]
Rodon, J. [1 ]
Vansteenkiste, J. F. [2 ]
Ando, Y. [3 ]
Doi, T. [4 ]
Mills, D. [5 ]
Sarr, C. [6 ]
Di Tomaso, E. [7 ]
Massacesi, C. [8 ]
Naumann, R. W. [9 ]
机构：
[1] Vall dHebron Univ Hosp, Barcelona, Spain
[2] Univ Hosp Gasthuisberg, Resp Oncol Unit, B-3000 Louvain, Belgium
[3] Nagoya Univ Hosp, Dept Clin Oncol & Chemotherapy, Nagoya, Aichi, Japan
[4] Natl Canc Ctr Hosp, Gastrointestinal Oncol Div, Chiba, Japan
[5] Novartis Pharma AG, Stat, Basel, Switzerland
[6] Novartis Pharma AG, Modeling, Basel, Switzerland
[7] Novartis Inst Biomed Res, Cambridge, MA USA
[8] Novartis Oncol, Global Clin Program, Paris, France
[9] Carolinas Med Ctr, Div Gynecol Oncol, Charlotte, NC 28203 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
884
引用
收藏
页码：S186 / S186
页数：1
相关论文
共 50 条
  • [21] ERK-dependent IL-6 autocrine signaling mediates adaptive resistance to pan-PI3K inhibitor BKM120 in head and neck squamous cell carcinoma
    Yun, M. R.
    Choi, H. M.
    Kang, H. N.
    Lee, Yw
    Joo, H-S
    Kim, D. H.
    Kim, H. R.
    Hong, M. H.
    Yoon, S. O.
    Cho, B. C.
    ONCOGENE, 2018, 37 (03) : 377 - 388
  • [22] SU2C phase Ib study of pan-PI3K inhibitor BKM120 with letrozole in ER+/HER2-metastatic breast cancer (MBC).
    Mayer, Ingrid A.
    Abramson, Vandana Gupta
    Balko, Justin M.
    Isakoff, Steven J.
    Kuba, Maria Gabriela
    Sanders, Melinda
    Forero-Torres, Andres
    Yap, Jeffrey T.
    Van Den Abbeele, Annick D.
    Li, Yisheng
    Arteaga, Carlos L.
    Winer, Eric P.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [23] BKM120 is cytotoxic in neuroblastoma targeting the PI3K pathway
    Pomaville, Monica M.
    Zhao, Ping
    Decou, Sarah
    Nagulapally, Abhinav B.
    Bond, Jeffrey
    Sholler, Giselle L. Saulnier
    CANCER RESEARCH, 2016, 76
  • [24] The PI3K inhibitor BKM120 inhibits growth of pancreatic ductal adenocarcinoma in vitro and in vivo
    Tignanelli, Christopher James
    Herrera, Silvia Gabriela
    Torphy, Robert
    Yeh, Jen Jen
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2013, 217 (03) : S137 - S138
  • [25] Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagy
    Peng, Xin
    Zhang, Shaolu
    Jiao, Wenhui
    Zhong, Zhenxing
    Yang, Yuqi
    Claret, Francois X.
    Elkabets, Moshe
    Wang, Feng
    Wang, Ran
    Zhong, Yuxu
    Chen, Zhe-Sheng
    Kong, Dexin
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021, 40 (01)
  • [26] PRE-CLINICAL ACTIVITY OF THE PI3K INHIBITOR BKM120 ON ACUTE MYELOID LEUKEMIA
    Allegretti, M.
    Ricciardi, M. R.
    Licchetta, R.
    Mirabilii, S.
    Amadori, S.
    Foa, R.
    Tafuri, A.
    HAEMATOLOGICA, 2014, 99 : 291 - 291
  • [27] SU2C Phase Ib Study of pan-PI3K Inhibitor BKM120 Plus Aromatase Inhibitor Letrozole in ER+/HER2-Metastatic Breast Cancer (MBC).
    Mayer, I. A.
    Balko, J. M.
    Kuba, M. G.
    Sanders, M. E.
    Yap, J.
    Li, Y.
    Winer, E.
    Arteaga, C. L.
    CANCER RESEARCH, 2011, 71
  • [28] Phase II trial of the phosphatidyinositol-3 kinase (PLIK) inhibitor buparlisib (BKM120) in recurrent glioblastoma
    Wen, Patrick Y.
    Yung, W. K. Alfred
    Mellinghoff, Ingo K.
    Ramkissoon, Shakti
    Alexander, Brian Michael
    Rinne, Mikael L.
    Colman, Howard
    Omura, Antonio MarcIllo Paduia
    DeAngelis, Lisa Marie
    Gilbert, Mark R.
    De Groot, John Frederick
    Cloughesy, Timothy Francis
    Chi, Andrew S.
    Lee, Eudocia Quant
    Nayak, Lakshmi
    Batchelor, Tracy
    Chang, Susan Marina
    Prados, Michael
    Reardon, David A.
    Ligon, Keith L.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [29] Phase 2 study of the pan-isoform PI3 kinase inhibitor BKM120 in metastatic urothelial carcinoma patients.
    Iyer, Gopa
    Tully, Christopher Michael
    Garcia-Grossman, Ilana Rebecca
    Scott, Sasinya N.
    Boyd, Mariel Elena
    Mccoy, Asia S.
    Berger, Michael F.
    Al-Ahmadie, Hikmat
    Solit, David B.
    Rosenberg, Jonathan E.
    Bajorin, Dean F.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [30] Discovery of BKM120, a pan class I PI3 kinase inhibitor in phase I/II clinical trials
    Burger, Matthew T.
    Pecchi, Sabina
    Wagman, Allan
    Ni, Zhi-Jie
    Knapp, Mark
    Atallah, Gordana
    Pfister, Keith
    Ng, Simon
    Smith, Aaron
    Pick, Teresa
    Frazier, Kelly
    Verhagen, Joelle
    Zhang, Yanchen
    Bartulis, Sarah
    Hendricksen, Tom
    Iwanowicz, Edwin
    Hazenadar, Joshua
    Huh, Kay
    Ashash, Ahmad
    Xin, Xiaohua
    Menezes, Daniel
    Merritt, Hanne
    Wiesmann, Marion
    Voliva, Charles
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
12345